Search Results

There are 9096 results for: content related to: A changing treatment landscape for multiple sclerosis: challenges and opportunities

  1. You have free access to this content
    New and emerging immune-targeted drugs for the treatment of multiple sclerosis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 33–43, Alan M. Palmer

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12285

  2. You have free access to this content
    Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico and Graziella Filippini

    Published Online : 18 SEP 2015, DOI: 10.1002/14651858.CD011381.pub2

  3. A prospective, open-label treatment trial to compare the effect of IFN β-1a (Avonex), IFNβ-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

    European Journal of Neurology

    Volume 8, Issue 2, March 2001, Pages: 141–148, O. A. Khan, A. C. Tselis, J. A. Kamholz, J. Y. Garbern, R. A. Lewis and R. P. Lisak

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1468-1331.2001.00189.x

  4. You have full text access to this OnlineOpen article
    A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 5, May 2015, Pages: 295–304, A Gulati, F Bagnato, P Villoslada and N Velez de Mendizabal

    Version of Record online : 24 APR 2015, DOI: 10.1002/psp4.36

  5. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

    Annals of Neurology

    Volume 78, Issue 1, July 2015, Pages: 115–127, Federica Esposito, Melissa Sorosina, Linda Ottoboni, Elaine T. Lim, Joseph M. Replogle, Towfique Raj, Paola Brambilla, Giuseppe Liberatore, Clara Guaschino, Marzia Romeo, Thomas Pertel, James M. Stankiewicz, Vittorio Martinelli, Mariaemma Rodegher, Howard L. Weiner, David Brassat, Christophe Benoist, Nikolaos A. Patsopoulos, Giancarlo Comi, Wassim Elyaman, Filippo Martinelli Boneschi and Philip L. De Jager

    Version of Record online : 14 MAY 2015, DOI: 10.1002/ana.24429

  6. Effectiveness of interferon beta treatment in relapsing-remitting multiple sclerosis: an Italian cohort study

    Journal of Evaluation in Clinical Practice

    Volume 10, Issue 4, November 2004, Pages: 511–518, Pierluigi Russo, Andrea Paolillo, Luciano Caprino, Stefano Bastianello and Placido Bramanti

    Version of Record online : 8 OCT 2004, DOI: 10.1111/j.1365-2753.2003.00436.x

  7. You have free access to this content
    Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis

    Value in Health

    Volume 5, Issue 1, January 2002, Pages: 44–54, Mark J. C. Nuijten and John Hutton

    Version of Record online : 21 MAR 2002, DOI: 10.1046/j.1524-4733.2002.51052.x

  8. Fingolimod for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Irene Tramacere, Belal Firwana, Ilaria Pacchetti, Roberto Palumbo and Graziella Filippini

    Published Online : 19 APR 2016, DOI: 10.1002/14651858.CD009371.pub2

  9. You have free access to this content
    Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

    European Journal of Immunology

    Volume 40, Issue 10, October 2010 , Pages: 2942–2956, Christopher T. Harp, Sara Ireland, Laurie S. Davis, Gina Remington, Bonnie Cassidy, Petra D. Cravens, Olaf Stuve, Amy E. Lovett-Racke, Todd N. Eagar, Benjamin M. Greenberg, Michael K. Racke, Lindsay G. Cowell, Nitin J. Karandikar, Elliot M. Frohman and Nancy L. Monson

    Version of Record online : 1 SEP 2010, DOI: 10.1002/eji.201040516

  10. You have free access to this content
    Rituximab for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Dian He, Rui Guo, Fubo Zhang, Chao Zhang, Shuai Dong and Hongyu Zhou

    Published Online : 6 DEC 2013, DOI: 10.1002/14651858.CD009130.pub3

  11. An information systems design product theory for the class of integrated requirements and release management systems

    Journal of Software Maintenance and Evolution: Research and Practice

    Volume 23, Issue 6, October 2011, Pages: 443–463, Timo Käkölä, Mervi Koivulahti-Ojala and Jani Liimatainen

    Version of Record online : 3 SEP 2010, DOI: 10.1002/smr.492

  12. You have free access to this content
    Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population

    Value in Health

    Volume 12, Issue 5, July/August 2009, Pages: 657–665, Paul Tappenden, Christopher McCabe, Jim Chilcott, Emma Simpson, Richard Nixon, Jason Madan, John D. Fisk and Murray Brown

    Version of Record online : 12 JAN 2009, DOI: 10.1111/j.1524-4733.2008.00485.x

  13. You have full text access to this OnlineOpen article
    Beta-interferon exposure and onset of secondary progressive multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue 6, June 2015, Pages: 990–1000, T. Zhang, A. Shirani, Y. Zhao, M. E. Karim, P. Gustafson, J. Petkau, C. Evans, E. Kingwell, M. van der Kop, F. Zhu, J. Oger, H. Tremlett and BC MS Clinic Neurologists

    Version of Record online : 6 APR 2015, DOI: 10.1111/ene.12698

  14. Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

    European Journal of Neurology

    Volume 15, Issue 4, April 2008, Pages: 386–393, A. Carrá, P. Onaha, G. Luetic, M. Burgos, E. Crespo, N. Deri, M. Halfon, G. Jaacks, A. López, V. Sinay and C. Vrech

    Version of Record online : 18 MAR 2008, DOI: 10.1111/j.1468-1331.2008.02071.x

  15. You have free access to this content
    Dimethyl fumarate for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Zhu Xu, Feng Zhang, FangLi Sun, KeFeng Gu, Shuai Dong and Dian He

    Published Online : 22 APR 2015, DOI: 10.1002/14651858.CD011076.pub2

  16. You have free access to this content
    New natural history of interferon-β–treated relapsing multiple sclerosis

    Annals of Neurology

    Volume 61, Issue 4, April 2007, Pages: 300–306, Maria Trojano, Fabio Pellegrini, Aurora Fuiani, Damiano Paolicelli, Valentina Zipoli, Giovanni B. Zimatore, Elisabetta Di Monte, Emilio Portaccio, Vito Lepore, Paolo Livrea and Maria Pia Amato

    Version of Record online : 19 APR 2007, DOI: 10.1002/ana.21102

  17. You have free access to this content
    Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 359–372, N. Melzer and S. G. Meuth

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12195

  18. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  19. You have free access to this content
    Established and novel disease-modifying treatments in multiple sclerosis

    Journal of Internal Medicine

    Volume 275, Issue 4, April 2014, Pages: 350–363, A. H. Cross and R. T. Naismith

    Version of Record online : 11 MAR 2014, DOI: 10.1111/joim.12203

  20. Teriflunomide for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Dian He, Chao Zhang, Xia Zhao, Yifan Zhang, Qingqing Dai, Yuan Li and Lan Chu

    Published Online : 22 MAR 2016, DOI: 10.1002/14651858.CD009882.pub3